Jane Street
PBE icon

Jane Street’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Jane Street’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$422K Buy
+4,712
New +$388K ﹤0.01% 8418
2024
Q4 		– Sell
-4,221
Closed -$295K – 10252
2024
Q3 		$295K Buy
+4,221
New +$292K ﹤0.01% 8062
2020
Q2 		– Sell
-12,217
Closed -$568K – 7436
2020
Q1 		$568K Buy
12,217
+5,548
+83% +$289K ﹤0.01% 3490
2019
Q4 		$372K Sell
6,669
-78
-1% -$4.07K ﹤0.01% 4033
2019
Q3 		$320K Sell
6,747
-10,971
-62% -$562K ﹤0.01% 4099
2019
Q2 		$948K Buy
+17,718
New +$919K ﹤0.01% 2768
2018
Q3 		– Sell
-11,791
Closed -$645K – 5548
2018
Q2 		$645K Sell
11,791
-3,055
-21% -$155K ﹤0.01% 3297
2018
Q1 		$731K Buy
14,846
+7,650
+106% +$390K ﹤0.01% 3034
2017
Q4 		$339K Buy
7,196
+2,064
+40% +$96.7K ﹤0.01% 3619
2017
Q3 		$256K Buy
+5,132
New +$243K ﹤0.01% 3868
2017
Q1 		– Sell
-12,900
Closed -$501K – 4540
2016
Q4 		$501K Sell
12,900
-2,377
-16% -$96K ﹤0.01% 2862
2016
Q3 		$641K Sell
15,277
-1,008
-6% -$41.4K ﹤0.01% 2492
2016
Q2 		$602K Buy
16,285
+8,324
+105% +$326K ﹤0.01% 2572
2016
Q1 		$305K Sell
7,961
-23,608
-75% -$917K ﹤0.01% 3181
2015
Q4 		$1.59M Sell
31,569
-4,880
-13% -$241K 0.01% 1277
2015
Q3 		$1.67M Buy
+36,449
New +$2.04M 0.01% 1152
2015
Q2 		– Sell
-44,647
Closed -$2.46M – 3924
2015
Q1 		$2.46M Buy
+44,647
New +$2.41M 0.02% 741
2014
Q3 		– Sell
-5,418
Closed -$237K – 2920
2014
Q2 		$237K Sell
5,418
-97,653
-95% -$3.96M ﹤0.01% 2057
2014
Q1 		$4.29M Buy
+103,071
New +$4.41M 0.05% 280

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.75B AUM 28.61% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
YIA
YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return

Jane Street's PBE Position: Q2 2026 in Review

Jane Street opened a new position in Invesco Biotechnology & Genome ETF (PBE) in Q2 2026: 4,712 shares worth $422K. The stake represents ﹤0.01% of the portfolio and ranks #8418 among its holdings. This is a return to the name: Jane Street previously reported a position in PBE as recently as Q3 2024.

Jane Street first reported a position in PBE in Q1 2014 and has held it in 19 quarters since. The position peaked at $4.29M in Q1 2014. 105 funds tracked by Wall St. Rank hold PBE as of Q2 2026.

  • Jane Street held 4,712 shares of Invesco Biotechnology & Genome ETF worth $422K as of Q2 2026.
  • Invesco Biotechnology & Genome ETF was a new Jane Street position in Q2 2026.
  • Invesco Biotechnology & Genome ETF made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8418 holding.
  • Jane Street first reported a position in Invesco Biotechnology & Genome ETF in Q1 2014 and has held it in 19 quarters since.
  • Jane Street's Invesco Biotechnology & Genome ETF position peaked at $4.29M in Q1 2014.
  • 105 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.